Member Info for Propinquity

Thanks for the heads-up; shame RL didn’t have the decency to respond to my e-mail, which I sent last Friday - unless I got the wrong address.

I would delightedly squirrel away my Keras shares only if good news on Togo accompanies the CAI disbursement, whereby KRS itself becomes wholly self-sustaining (in other words, without relying on CAI to augment its value).

Come on, SBK, find out for us - you know you want to.

You must be the class favourite.

Sent Russell an e-mail, on Friday - still awaiting a response.

Sammy, Possibly less a contradiction and more an implication a project - or two - may realise more value significantly quicker by a JV injection than by wholly internal funding.

I’d still rather remain in a company that covers its own overheads and pays for its own projects - even with a lower budget and a slower pace than we would all like - not many AIM companies - let alone mining ones - who could be as self-financing as we are.

SBK, I should hope that that person was the main reason for stymieing the approval; the consensus of this board, however, seems to place hope in Calidus’s capability to compensate for our losses - both financially and faithfully - in Keras.

Thanks for confirming, Jim; I have sent Russell a diplomatically worded e-mail - it was difficult to stem my frustration seeping from my mind, through my arms, and to my fingers while I was composing it.

Chirpster, Thanks.

Would someone please be so kind as to post Russell’s e-mail address or tell me where to find it.

Mohsin, You’ll probably profit nicely from this one if you’re in for the long haul.

My investment strategy is exactly that: short-term trading always sees my losing money.

Mohsin, The following excerpt from the September 11th RNS may clarify it for you:

'Prior to completion of the Transaction, registered shareholders in Amryt, on the CVR Record Date, will (conditional on closing of the Transaction occurring) receive CVRs pursuant to which up to $85 million may become payable to Amryt's existing Shareholders and Option holders if certain approval and revenue milestones are met in relation to one of Amryt's principal products, AP101. The CVR Record Date is 20 September 2019. If Shareholders sell their Ordinary Shares in advance of the CVR Record Date they will not be entitled to receive CVRs. The value of these CVRs is up to US$1.48 per Ordinary Share (£1.22 based upon an exchange rate of £1:$1.21).'

And three months has passed since - hey-ho, maybe the definition of 'imminent' is subjective - but my interpretation of it is 'about to happen'.

Devon, As long as it’s three times our current share-price.

Still baffled about the purported other projects that he mentions; quite frankly, I would rather Russell resolve the Togo one before he embarks on other ne’er ending projects.

See my post on Sept 12th.

that pre-eminent investor Warren Buffet:

We simply attempt to be fearful when others are greedy and to be greedy only when others are fearful.

Price is what you pay. Value is what you get.

Someone's sitting in the shade today because someone planted a tree a long time ago.

DV, You should be our company broker - you'd be more professional, reliable, and accurate than the poorly researched incumbent, SP Angel.

Trout, Fairly certain that they'll package the progress-update into the interims; I am of the mindset that the BoD will henceforth be less ebullient - reducing the usage of words such as 'juggernaut', 'dividends', and 'tsunami of cash' - and instead presenting (for example, via interviews) a staid manner.

Blacksheep, Indeed, the silence has sheared many nerves while cloaking the company in wooliness.